148 related articles for article (PubMed ID: 8437006)
1. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.
Sharief MK; Thompson EJ
J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):169-74. PubMed ID: 8437006
[TBL] [Abstract][Full Text] [Related]
2. In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.
Sharief MK; Hentges R; Ciardi M; Thompson EJ
J Neurol; 1993 Jan; 240(1):46-50. PubMed ID: 8423463
[TBL] [Abstract][Full Text] [Related]
3. The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis.
Sharief MK; Hentges R; Thompson EJ
J Neuroimmunol; 1991 Apr; 32(1):43-51. PubMed ID: 2002090
[TBL] [Abstract][Full Text] [Related]
4. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
Gallo P; Piccinno MG; Pagni S; Argentiero V; Giometto B; Bozza F; Tavolato B
J Neurol Sci; 1989 Aug; 92(1):9-15. PubMed ID: 2504888
[TBL] [Abstract][Full Text] [Related]
5. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.
Shaw CE; Dunbar PR; Macaulay HA; Neale TJ
J Neurol; 1995 Jan; 242(2):53-8. PubMed ID: 7707089
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum.
Gallo P; Piccinno MG; Tavolato B; Sidén A
J Neurol Sci; 1991 Feb; 101(2):227-32. PubMed ID: 1827837
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls.
Sivieri S; Ferrarini AM; Gallo P
Mult Scler; 1998 Feb; 4(1):7-11. PubMed ID: 9532585
[TBL] [Abstract][Full Text] [Related]
8. Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis.
Freedman MS; Muth KL; Trotter JL; Yoshizawa CN; Antel JP
Neurology; 1992 Aug; 42(8):1596-601. PubMed ID: 1641157
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
[TBL] [Abstract][Full Text] [Related]
10. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
11. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
Bilińska M; Frydecka I; Podemski R
Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
[TBL] [Abstract][Full Text] [Related]
12. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.
Chalon MP; Sindic CJ; Laterre EC
Acta Neurol Scand; 1993 Feb; 87(2):77-82. PubMed ID: 8442399
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
Ott M; Demisch L; Engelhardt W; Fischer PA
J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
[TBL] [Abstract][Full Text] [Related]
14. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.
Ciardi M; Sharief MK; Thompson EJ; Salotti A; Vullo V; Sorice F; Cirelli A
J Neurol Sci; 1994 Sep; 125(2):175-9. PubMed ID: 7807163
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
16. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
Adachi K; Kumamoto T; Araki S
Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis.
Fesenmeier JT; Whitaker JN; Herman PK; Walker DP
J Neuroimmunol; 1991 Oct; 34(1):77-80. PubMed ID: 1716642
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies.
Ciardi M; Sharief MK; Noori MA; Thompson EJ; Salotti A; Rossi F; Vullo V; Catania S; Sorice F; Cirelli A
J Neurol Sci; 1993 Mar; 115(1):117-22. PubMed ID: 8468587
[TBL] [Abstract][Full Text] [Related]
19. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.
Ikeguchi R; Shimizu Y; Shimizu S; Kitagawa K
Mult Scler; 2018 Aug; 24(9):1212-1223. PubMed ID: 28657431
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin-2 receptor levels in chronic progressive, stable and steroid-treated multiple sclerosis.
Bansil S; Troiano R; Cook SD; Rohowsky-Kochan C
Acta Neurol Scand; 1991 Oct; 84(4):282-5. PubMed ID: 1772000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
